Home health testing technology has come a long way in recent years and, driven in part by the pandemic, is set to be worth $8.15bn by 2030. Dr Michelle Tempest and Alina Trabattoni of Candesic examine the exponential growth and, given the right investment, the democratisation of healthcare it could unleash globally.